Skip to main content

Sequence sPecific ELImination of shiga-Toxin E. Coli

Project description

A pioneering antibiotic against toxic bacteria enters clinical trials

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /natural sciences/biological sciences/genetics and heredity/mutation
  • /social sciences/economics and business
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

ELIGO BIOSCIENCE
Address
29 Rue Faubourg Saint Jacques Pepin
75014 Paris
France
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 763 775